Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms—A randomized controlled trial
Objectives This study investigates the efficacy and adverse events of beta‐3 agonists and
antimuscarinic agents for managing overactive bladder syndrome in Sjogren syndrome …
antimuscarinic agents for managing overactive bladder syndrome in Sjogren syndrome …
Effects of different urodynamic characteristics on therapeutic outcomes of overactive bladder medication in a real-life clinical practice
HJ Wang, HC Kuo - Tzu Chi Medical Journal, 2022 - journals.lww.com
Objective: This study retrospectively investigated the influence of urodynamic parameters
and patient characteristics on success rates among patients with overactive bladder (OAB) …
and patient characteristics on success rates among patients with overactive bladder (OAB) …
Hyperlipidemia as a risk factor for discontinuation of prescribed antimuscarinics among geriatric overactive bladder patients.
YC Chen, HW Chen, YS Juan - LUTS, 2019 - search.ebscohost.com
In our 10-year nationwide population-based cohort study in Taiwan,[5] up to 52.6% of OAB
patients using antimuscarinics for at least 3 months had concurrent hyperlipidemia, and …
patients using antimuscarinics for at least 3 months had concurrent hyperlipidemia, and …